[21 June 2012]
Products Affected - Description
Argatroban injection, Medicines Company
1 mg/mL, 50 mL vials, 1 count (NDC 42367-0203-07) - not currently manufactured
Reason for the Shortage
- Medicines Company distributes argatroban supplied by Eagle Pharmaceuticals. Eagle Pharmaceuticals has voluntarily recalled all lots of argatroban due to the potential for visible particulates.
- Sandoz had argatroban injection on shortage due to increased demand.
Available Products
Argatroban injection, GlaxoSmithKline
100 mg/mL, 2 mL vials (NDC 00007-4407-01)
100 mg/mL, 2 mL Novaplus vials (NDC 00007-4407-54)
Argatroban injection, Sandoz
1 mg/mL, 125 mL vial, 2 count (NDC 00781-3285-12)
Argatroban injection, Medicines Company
1 mg/mL, 50 mL vials, 10 count (NDC 42367-0203-84)
Estimated Resupply Dates
All presentations are available at this time.
Safety
Argatroban is available in various strengths and presentations. Ensure safe use of different presentations during this shortage.
Related Shortages
Updated
June 21, 2012; May 2, 2012; April 11, 2012; March 1, 2012; January 31, 2012; January 25, 2012; January 3, 2012; December 5, 2011; December 1, 2011, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins